A carregar...

Refractory primary immune thrombocytopenia with subsequent del(5q) MDS: complete remission of both after lenalidomide

A patient with refractory primary immune thrombocytopenia (ITP) characterised by severe skin and mucosal bleedings was treated with several ITP-directed therapies including cyclophosphamide. He later developed therapy-related del(5q) myelodysplastic syndrome with no dysplastic morphological features...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Case Rep
Main Authors: Mortensen, Thomas Bech, Frederiksen, Henrik, Marcher, Claus Werenberg, Preiss, Birgitte
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5256528/
https://ncbi.nlm.nih.gov/pubmed/28052942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-215888
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!